MedTrace Logo

Arthroscopy of the Temporomandibular Joint. On Jaw Mobility, Pain and HRQoL

NCT06433154 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2024-05-29

No results posted yet for this study

Summary

The aim of the present study is to retrospectively investigate whether arthroscopic treatment in patients with TMD symptoms depending on internal derangement of the temporomandibular joint (TMJ) gives a satisfying result on the patient's quality of life.

Based on previous studies it is hypothesized that patients suffering from TMD depending on internal derangement would through Patient Reported Outcome Measures (PROM) evaluate the treatment efficacy from an arthroscopic treatment as a benefit to their quality of life.

Further, the study intends to find out if the patient reported outcome measures (PROM) on health-related quality of life (HRQoL) outcome correlates with clinical follow-up measures after arthroscopic treatment of internal derangement of the temporomandibular joint.

The primary objective is to measure the correlation between the results from a HRQoL questionnaire and mouth opening. Secondary, the effect of mouth opening on HRQoL is being explored.

The primary prediction variable is the surgical treatment. Outcome variables are treatment evaluation quality of life (PROM) based on a validated questionnaire; Jaw Functional Limitation Scale (JFLS), age, gender, time from diagnosis to treatment, severity of symptoms (pain, mouth opening ability) and time from treatment to evaluation.

Conditions

  • Arthroscopic Surgery
  • Temporomandibular Joint
  • Health-Related Quality Of Life
  • Follow-Up Studies
  • Observational

Interventions

PROCEDURE

Arthroscopic surgery

Arthroscopic treatment (lysis and lavage) of internal derangement of the temporomandibular joint.

Sponsors & Collaborators

  • Lund University Hospital

    lead OTHER

Principal Investigators

  • Martin Bengtsson, DDS, PhD · Lund University Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-12-31
Completion
2024-03-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06433154 on ClinicalTrials.gov